This is where we differ. For me it comes down to one thing - if Medinah lands a joint venture with a "respectable" partner, the underperformance of the previous years will be long forgotten as it was when the stock ran to .19 in 2011, and later to the .17 range with Amarant. The authorized shares are meaningless unless and until they are used.
When you spend more time on this stock you might be able to see what the longs have been talking about. I do respect your due diligence but facts are facts and the results will never change unless you change either the players, the method in which this organization has been conducting business, and the owner. All that has happened in too many years needs to change to see this stock turning around.